Status:
COMPLETED
Improved HRV, Inflammation Markers and Endothelial Function After TAVI
Lead Sponsor:
University Medical Centre Ljubljana
Conditions:
Severe Aortic Stenosis
TAVI
Eligibility:
All Genders
18+ years
Brief Summary
Severe aortic valve stenosis is known to affect heart haemodynamics, endothelial function and body inflammation markers. Our aim is to investigate the weather transcatheter aortic valve implantation i...
Eligibility Criteria
Inclusion
- TAVI
Exclusion
- stage V chronic kidney disease
- active malignancies
Key Trial Info
Start Date :
July 9 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04286893
Start Date
July 9 2019
End Date
July 31 2020
Last Update
November 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UMC Ljubljana
Ljubljana, Slovenia, 1000